参考文献/References:
[1] ABOYANS V, RICCO J B, BARTELINK M E L, et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS) [J]. Eur Heart J, 2018, 39(9): 763-816.
[2] STEG P G, BHATT D L, WILSON P W, et al. One-year cardiovascular event rates in outpatients with atherothrombosis [J]. JAMA, 2007, 297(11): 1197-206.
[3] SYED A, HASHMANI S, DARR U, et al. Polyvascular Disease in the Gulf Region: Concealed Marker of Poor Outcomes in Acute Coronary Syndrome [J]. Curr Probl Cardiol, 2022, 47(12): 101357.
[4] MENG X, CHEN Y, JING J, et al. Association between polyvascular atherosclerosis and estimated glomerular filtration rate in patients with ischaemic stroke: data analysis of the patients in the Chinese National Stroke Registry [J]. Neurol Res, 2015, 37(5): 415-20.
[5] COLLEDANCHISE K N, MANTELLA L E, BULLEN M, et al. Combined Femoral and Carotid Plaque Burden Identifies Obstructive Coronary Artery Disease in Women [J]. J Am Soc Echocardiogr, 2020, 33(1): 90-100.
[6] HAN Y, REN L, FEI X, et al. Association between Carotid Intraplaque Neovascularization Detected by Contrast-Enhanced Ultrasound and the Progression of Coronary Lesions in Patients Undergoing Percutaneous Coronary Intervention [J]. J Am Soc Echocardiogr, 2023, 36(2): 216-23.
[7] KAFETZAKIS A, KOCHIADAKIS G, LALIOTIS A, et al. Association of subclinical wall changes of carotid, femoral, and popliteal arteries with obstructive coronary artery disease in patients undergoing coronary angiography [J]. Chest, 2005, 128(4): 2538-43.
[8] GAIBAZZI N, RIGO F, FACCHETTI R, et al. Differential incremental value of ultrasound carotid intima-media thickness, carotid plaque, and cardiac calcium to predict angiographic coronary artery disease across Framingham risk score strata in the APRES multicentre study [J]. Eur Heart J Cardiovasc Imaging, 2016, 17(9): 991-1000.
[9] HE J, CHEN P, LUO Y, et al. Relationship between the maximum carotid plaque area and the severity of coronary atherosclerosis [J]. Int Angiol, 2018, 37(4): 300-9.
[10] WEISSGERBER A, SCHOLZ M, TEREN A, et al. The value of noncoronary atherosclerosis for identifying coronary artery disease: results of the Leipzig LIFE Heart Study [J]. Clin Res Cardiol, 2016, 105(2): 172-81.
[11] SUZUKI M, OKAWA M, OKUNO Y, et al. Prevalence of carotid artery stenosis with coronary artery disease in Japanese patients: A single-center study [J]. J Neurol Sci, 2022, 443(120492.
[12] COLLEDANCHISE K N, MANTELLA L E, HETU M F, et al. Femoral plaque burden by ultrasound is a better indicator of significant coronary artery disease over ankle brachial index [J]. Int J Cardiovasc Imaging, 2021, 37(10): 2965-73.
[13] HAMIRANI Y S, LARIJANI V, ISMA’EEL H, et al. Association of plaque in the carotid and coronary arteries, using MDCT angiography [J]. Atherosclerosis, 2010, 211(1): 141-5.
[14] SHIN H S, JUNG PARK M, NYEO JEON K, et al. Lower Extremity Arterial Calcification as a Predictor of Coronary Atherosclerosis in Patients with Peripheral Arterial Disease [J]. Iran J Radiol, 2016, 13(2): e33179.
[15] SELWANESS M, BOS D, VAN DEN BOUWHUIJSEN Q, et al. Carotid Atherosclerotic Plaque Characteristics on Magnetic Resonance Imaging Relate With History of Stroke and Coronary Heart Disease [J]. Stroke, 2016, 47(6): 1542-7.
[16] UNDERHILL H R, YUAN C, TERRY J G, et al. Differences in carotid arterial morphology and composition between individuals with and without obstructive coronary artery disease: a cardiovascular magnetic resonance study [J]. J Cardiovasc Magn Reson, 2008, 10(1): 31.
[17] SAITO K, NAGATSUKA K, ISHIBASHI-UEDA H, et al. Contrast-enhanced ultrasound for the evaluation of neovascularization in atherosclerotic carotid artery plaques [J]. Stroke, 2014, 45(10): 3073-5.
[18] QIN C, ZHANG L, WANG X, et al. Evaluation of Carotid Plaque Neovascularization in Patients With Coronary Heart Disease on Contrast-Enhanced Ultrasonography [J]. J Ultrasound Med, 2018, 37(4): 823-31.
[19] KWON J E, MINTZ G S, KIM S W, et al. Relationship between coronary artery plaque composition by virtual histology intravascular ultrasound analysis and brachial-ankle pulse wave velocity in patients with coronary artery disease [J]. Coron Artery Dis, 2011, 22(8): 565-9.
[20] KATO A, MINAMI Y, ASAKURA K, et al. Characteristics of carotid atherosclerosis in patients with plaque erosion [J]. J Thromb Thrombolysis, 2021, 52(2): 620-7.
[21] JANG W J, PARK I H, YANG J H, et al. Association between polyvascular disease and clinical outcomes in patients with cardiogenic shock: Results from the RESCUE registry [J]. Int J Cardiol, 2021, 339(70-4.
[22] COLANTONIO L D, HUBBARD D, MONDA K L, et al. Atherosclerotic Risk and Statin Use Among Patients With Peripheral Artery Disease [J]. J Am Coll Cardiol, 2020, 76(3): 251-64.
[23] GRUNDY S M, STONE N J, BAILEY A L, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines [J]. Circulation, 2019, 139(25): e1082-e143.
[24] AL THANI H, EL-MENYAR A, ALHABIB K F, et al. Polyvascular disease in patients presenting with acute coronary syndrome: its predictors and outcomes [J]. ScientificWorldJournal, 2012, 2012(284851.
[25] FERREIRA-GONZALEZ I, PERMANYER MIRALDA G, HERAS M, et al. Prognosis and management of patients with acute coronary syndrome and polyvascular disease [J]. Rev Esp Cardiol, 2009, 62(9): 1012-21.
[26] NONIN S, IWATA S, SUGIOKA K, et al. Plaque surface irregularity and calcification length within carotid plaque predict secondary events in patients with coronary artery disease [J]. Atherosclerosis, 2017, 256(29-34.
[27] KOCYIGIT D, GURSES K M, TAYDAS O, et al. Role of femoral artery ultrasound imaging in cardiovascular event risk prediction in a primary prevention cohort at a medium-term follow-up [J]. J Cardiol, 2020, 75(5): 537-43.
[28] BABER U, MEHRAN R, SARTORI S, et al. Prevalence, impact, and predictive value of detecting subclinical coronary and carotid atherosclerosis in asymptomatic adults: the BioImage study [J]. J Am Coll Cardiol, 2015, 65(11): 1065-74.
[29] BRUNNER G, VIRANI S S, SUN W, et al. Associations Between Carotid Artery Plaque Burden, Plaque Characteristics, and Cardiovascular Events: The ARIC Carotid Magnetic Resonance Imaging Study [J]. JAMA Cardiol, 2021, 6(1): 79-86.
[30] BOS D, ARSHI B, VAN DEN BOUWHUIJSEN Q J A, et al. Atherosclerotic Carotid Plaque Composition and Incident Stroke and Coronary Events [J]. J Am Coll Cardiol, 2021, 77(11): 1426-35.
相似文献/References:
[1]李乐亮,综述,李萍,等.炎症标志物与颈动脉粥样斑块的稳定性[J].心血管病学进展,2016,(3):219.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.001]
LI Leliang,LI Ping.Stability of Inflammatory Markers and Carotid Artery Plaque[J].Advances in Cardiovascular Diseases,2016,(12):219.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.001]
[2]耿春晖 关秀茹.MicroRNA作为动脉粥样硬化的诊断生物标志物的研究进展[J].心血管病学进展,2019,(7):996.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.008]
GENG Chunhui,GUAN Xiuru.microRNA as a Diagnostic Biomarker for Atherosclerosis[J].Advances in Cardiovascular Diseases,2019,(12):996.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.008]
[3]乐健 何胜虎.前蛋白转化酶枯草溶菌素9致动脉粥样硬化的机制研究进展[J].心血管病学进展,2019,(7):1000.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.009]
YUE Jian,HE Shenghu.Advances in the mechanism of PCSK9-induced atherosclerosis[J].Advances in Cardiovascular Diseases,2019,(12):1000.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.009]
[4]武亚琳,梁斌,杨志明.NLRP3/IL-1β途径的促动脉粥样硬化作用及临床应用[J].心血管病学进展,2019,(6):943.[doi:10.16806/j.cnki.issn.1004-3934.2016.06.026]
WU Yalin,LIANG Bin,YANG Zhiming.The Role of NLRP3/IL-1in Atherosclerosis and Clinical Application[J].Advances in Cardiovascular Diseases,2019,(12):943.[doi:10.16806/j.cnki.issn.1004-3934.2016.06.026]
[5]李琦玉 ?张宁 陈婧 黄浙勇.动脉粥样硬化的抗血小板分子靶向治疗[J].心血管病学进展,2019,(5):701.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.010]
LI Qiyu,ZHANG Ning,CHEN Jing,et al.Anti-Platelet Molecular Targeted Therapy or Atherosclerosis[J].Advances in Cardiovascular Diseases,2019,(12):701.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.010]
[6]侯冬华 郝丽荣.长正五聚蛋白3在动脉粥样硬化和心血管疾病中作用研究的新进展[J].心血管病学进展,2019,(5):805.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.035]
HOU Donghua H AO Lirong.The Study of Atherosclerosis and Cardiovascular Diseases with Pentapycin 3[J].Advances in Cardiovascular Diseases,2019,(12):805.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.035]
[7]焦新峰 刘正霞 鲁翔.白介素-8在冠心病中的研究进展[J].心血管病学进展,2019,(8):1126.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.014]
JIAO Xinfeng,LIU Zhengxia,LU Xiang.Research Progress of Interleukin-8 in Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2019,(12):1126.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.014]
[8]徐侨 刘正霞 鲁翔.白介素22在动脉粥样硬化和2型糖尿病中的作用[J].心血管病学进展,2019,(9):1260.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.019]
XU Qiao,LIU Zhengxia,LU Xiang.IL-22 in Atherosclerosis and Type 2 Diabetes Mellitus[J].Advances in Cardiovascular Diseases,2019,(12):1260.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.019]
[9]石文坚 花蕾 孟祥光 袁义强.环状RNA在冠状动脉粥样硬化性心脏病中的研究进展[J].心血管病学进展,2019,(9):1286.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.026]
SHI Wenjian,HUA Lei,MENG Xiangguang,et al.CircRNA in Coronary Atherosclerotic Heart Disease[J].Advances in Cardiovascular Diseases,2019,(12):1286.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.026]
[10]代承忠 彭礼清 余建群 刘静 蒲华霞.双源CT血管成像评价经导管主动脉瓣置入术术前患者颈动脉斑块[J].心血管病学进展,2019,(8):1182.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.028]
DAI Chengzhong,PENG Liqing,YU Jianqun,et al.Evaluation of Carotid Arteries Plaques in Patients Referred for TAVI with Dual-source CT Angiography[J].Advances in Cardiovascular Diseases,2019,(12):1182.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.028]